| High performance plasma amyloid-β biomarkers for Alzheimer’s disease A Nakamura, N Kaneko, VL Villemagne, T Kato, J Doecke, V Doré, ... Nature 554 (7691), 249-254, 2018 | 1624 | 2018 |
| Metal-protein attenuation with iodochlorhydroxyquin (clioquinol) targeting Aβ amyloid deposition and toxicity in Alzheimer disease: a pilot phase 2 clinical trial CW Ritchie, AI Bush, A Mackinnon, S Macfarlane, M Mastwyk, ... Archives of neurology 60 (12), 1685-1691, 2003 | 1249 | 2003 |
| A haplotype map of the human genome D Altshuler Nature 437, 1299-1320, 2005 | 1204 | 2005 |
| Rapid restoration of cognition in Alzheimer's transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Aβ PA Adlard, RA Cherny, DI Finkelstein, E Gautier, E Robb, M Cortes, ... Neuron 59 (1), 43-55, 2008 | 799 | 2008 |
| Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron CJ Maynard, R Cappai, I Volitakis, RA Cherny, AR White, K Beyreuther, ... Journal of Biological Chemistry 277 (47), 44670-44676, 2002 | 470 | 2002 |
| Metals and amyloid‐β in Alzheimer's disease CJ Maynard, AI Bush, CL Masters, R Cappai, QX Li International journal of experimental pathology 86 (3), 147-159, 2005 | 448 | 2005 |
| The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers N Mattsson, U Andreasson, S Persson, H Arai, SD Batish, S Bernardini, ... Alzheimer's & Dementia 7 (4), 386-395. e6, 2011 | 438 | 2011 |
| Mitochondrial oxidative stress causes hyperphosphorylation of tau S Melov, PA Adlard, K Morten, F Johnson, TR Golden, D Hinerfeld, ... PloS one 2 (6), e536, 2007 | 430 | 2007 |
| CSF biomarker variability in the Alzheimer's Association quality control program N Mattsson, U Andreasson, S Persson, MC Carrillo, S Collins, S Chalbot, ... Alzheimer's & Dementia 9 (3), 251-261, 2013 | 405 | 2013 |
| Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-β1-42 PJ Crouch, R Blake, JA Duce, GD Ciccotosto, QX Li, KJ Barnham, ... Journal of Neuroscience 25 (3), 672-679, 2005 | 400 | 2005 |
| Degradation of the Alzheimer disease amyloid β-peptide by metal-dependent up-regulation of metalloprotease activity AR White, T Du, KM Laughton, I Volitakis, RA Sharples, ME Xilinas, ... Journal of Biological Chemistry 281 (26), 17670-17680, 2006 | 362 | 2006 |
| Increasing Cu bioavailability inhibits Aβ oligomers and tau phosphorylation PJ Crouch, LW Hung, PA Adlard, M Cortes, V Lal, G Filiz, KA Perez, ... Proceedings of the National Academy of Sciences 106 (2), 381-386, 2009 | 318 | 2009 |
| Clearance mechanisms of Alzheimer's amyloid-β peptide: implications for therapeutic design and diagnostic tests KA Bates, G Verdile, QX Li, D Ames, P Hudson, CL Masters, RN Martins Molecular psychiatry 14 (5), 469-486, 2009 | 317 | 2009 |
| The solubility of α‐synuclein in multiple system atrophy differs from that of dementia with Lewy bodies and Parkinson's disease BCV Campbell, CA McLean, JG Culvenor, WP Gai, PC Blumbergs, ... Journal of neurochemistry 76 (1), 87-96, 2001 | 254 | 2001 |
| The β-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism S Petratos, QX Li, AJ George, X Hou, ML Kerr, SE Unabia, I Hatzinisiriou, ... Brain 131 (1), 90-108, 2008 | 232 | 2008 |
| Selective intracellular release of copper and zinc ions from bis (thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-β peptide PS Donnelly, A Caragounis, T Du, KM Laughton, I Volitakis, RA Cherny, ... Journal of Biological Chemistry 283 (8), 4568-4577, 2008 | 228 | 2008 |
| Non-Aβ component of Alzheimer's disease amyloid (NAC) revisited: NAC and α-synuclein are not associated with Aβ amyloid JG Culvenor, CA McLean, S Cutt, BCV Campbell, F Maher, P Jäkälä, ... The American journal of pathology 155 (4), 1173-1181, 1999 | 211 | 1999 |
| The eye as a biomarker for Alzheimer's disease JKH Lim, QX Li, Z He, AJ Vingrys, VHY Wong, N Currier, J Mullen, BV Bui, ... Frontiers in neuroscience 10, 536, 2016 | 207 | 2016 |
| Plasma α-synuclein is decreased in subjects with Parkinson's disease QX Li, S San Mok, KM Laughton, CA McLean, R Cappai, CL Masters, ... Experimental neurology 204 (2), 583-588, 2007 | 199 | 2007 |
| In vitro characterization of Pittsburgh compound-B binding to Lewy bodies MT Fodero-Tavoletti, DP Smith, CA McLean, PA Adlard, KJ Barnham, ... Journal of Neuroscience 27 (39), 10365-10371, 2007 | 185 | 2007 |
